Stay updated on Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page
- Check3 days agoChange DetectedA new page revision identifier 'Revision: v3.7.0' has been added. The previous revision 'Revision: v3.6.6' has been removed, reflecting an update to the page's versioning.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's Revision value changed from v3.6.5 to v3.6.6. This indicates a minor update to the page without altering the displayed study details.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.4 to Revision: v3.6.5. This indicates a small internal update to the page software and does not modify study details or public-facing content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page shows a new revision tag (v3.6.4) replacing the previous v3.6.3, reflecting a software deployment/update to the page rendering.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page's revision label in the footer was updated. The older label (Revision: v3.6.0) was removed and a new label (Revision: v3.6.3) was added to reflect a site revision.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page now shows a recruitment status update and adds user-facing guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also includes a revision note indicating v3.6.0, and a formatting change from 'Intervention / Treatment' to 'Intervention/Treatment', along with removing the older 'Revision: v3.5.5'.SummaryDifference0.4%

Stay in the know with updates to Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Rollover Study in Duchenne Muscular Dystrophy Clinical Trial page.